At NINGBO INNO PHARMCHEM CO.,LTD., we recognize the critical importance of detailed information for effective pharmaceutical use, especially for life-saving medications like Erlotinib Hydrochloride. This compound is a cornerstone in the treatment of certain advanced cancers, and understanding its proper usage, including erlotinib hydrochloride dosage and potential erlotinib hydrochloride drug interactions, is paramount for patient safety and treatment success.

Erlotinib Hydrochloride, an EGFR inhibitor, is typically prescribed as a tablet for oral administration. The exact erlotinib hydrochloride dosage can vary significantly depending on the patient's condition, the type of cancer being treated (such as non-small cell lung cancer or pancreatic cancer), and individual response to the medication. It is crucial for patients to adhere strictly to the dosage prescribed by their healthcare provider. Doctors will often initiate treatment with a standard dose, but may adjust it based on therapeutic effect and the occurrence of side effects. For instance, erlotinib hydrochloride for lung cancer might be initiated at 150 mg once daily, while for pancreatic cancer, it might be 100 mg once daily in combination with gemcitabine. Always consult your physician for personalized dosing information.

When discussing erlotinib hydrochloride side effects, it's important to note that while they can be manageable, awareness is key. Common side effects reported include skin rash, diarrhea, and fatigue. Less common but more serious effects can involve lung, liver, or kidney issues. Patients should report any persistent or severe side effects to their doctor immediately. This vigilance is a critical part of the erlotinib hydrochloride targeted therapy approach, ensuring that the benefits of the treatment are maximized while minimizing risks.

Understanding erlotinib hydrochloride drug interactions is also vital. Erlotinib Hydrochloride can interact with various other medications, including certain antibiotics, antifungals, and anti-seizure drugs, as well as grapefruit juice and tobacco. These interactions can affect how Erlotinib Hydrochloride is absorbed and metabolized in the body, potentially altering its efficacy or increasing the risk of side effects. For example, medications that induce or inhibit CYP3A4, the primary enzyme metabolizing erlotinib, can significantly impact its blood levels. Therefore, patients must inform their doctor about all medications, supplements, and even dietary habits before starting treatment with Erlotinib Hydrochloride.

As a leading supplier of high-quality Active Pharmaceutical Ingredients (APIs), NINGBO INNO PHARMCHEM CO.,LTD. ensures that Erlotinib Hydrochloride meets stringent purity standards, supporting the safe and effective use of this vital medication. Our commitment extends to providing accurate information that aids healthcare professionals and patients in navigating the complexities of cancer treatment.